Details zur Publikation
|DOI / URL||Link|
|Titel (primär)||The OSIRIS Weight of Evidence approach: ITS mutagenicity and ITS carcinogenicity|
|Autor||Buist, H.; Aldenberg, T.; Batke, M.; Escher, S.; Klein Entink, R.; Kühne, R.; Marquart, H.; Pauné, E.; Rorije, E.; Schüürmann, G.; Kroese, D.;|
|Journal / Serie||Regulatory Toxicology and Pharmacology|
|POF III (gesamt)||T42;|
|Keywords||Bayes’ theorem; Carcinogenicity; Decision theory; In vitro; In vivo; Mutagenicity; QSARs; Read-across; Swing weighting; Testing strategies|
Risk assessment of chemicals usually implies data evaluation of in vivo tests in rodents to conclude on their hazards. The FP7 European project OSIRIS has developed integrated testing strategies (ITS) for relevant toxicological endpoints to avoid unnecessary animal testing and thus to reduce time and costs. This paper describes the implementation of ITS mutagenicity and carcinogenicity in the public OSIRIS webtool. The data requirements of REACH formed the basis for these ITS. The main goal was to implement procedures to reach a conclusion on the adequacy and validity of available data.
For the mutagenicity ITS a quantitative Weight of Evidence approach based on Bayesian statistics was developed and implemented. The approach allows an overall quality assessment of all available data for the five types of mutagenicity data requirements: in vitro bacterial mutagenicity, in vitro and in vivo chromosome aberration, in vitro and in vivo mammalian mutagenicity.
For the carcinogenicity ITS a tool was developed to evaluate the quality of studies not conforming (entirely) to guidelines. In a tiered approach three quality aspects are assessed: documentation (reliability), study design (adequacy) and scope of examination (validity). The quality assessment is based on expert and data driven quantitative Weight of Evidence.
|Buist, H., Aldenberg, T., Batke, M., Escher, S., Klein Entink, R., Kühne, R., Marquart, H., Pauné, E., Rorije, E., Schüürmann, G., Kroese, D. (2013):
The OSIRIS Weight of Evidence approach: ITS mutagenicity and ITS carcinogenicity
Regul. Toxicol. Pharmacol. 67 (2), 170 - 181